BIONEUTRAL

BIO Revenue Growth (YoY) Analysis

-0.1%

Higher than 13% of Healthcare sector peers

Updated 414h ago·SEC filings & market data

Key Takeaway

Bio-Rad's current Revenue Growth (YoY) of 1.1% means that its total sales increased by just over one percent compared to the same quarter last year, a measure of how fast the business is expanding.

Sector Performance

13th percentile

BIO

-0.1%

Sector Median

10.0%

Sector Avg

12.8%

Prior Period

1.1%(Jul 2026)

↓ Declining

📊

Deep Analysis

Bio-Rad's current Revenue Growth (YoY) of 1.1% means that its total sales increased by just over one percent compared to the same quarter last year, a measure of how fast the business is expanding.

This is below the sector median of 6.2%, placing Bio-Rad in the 26th percentile among Healthcare peers, meaning 74% of comparable companies posted higher growth. Trend data is not available: the year-over-year change is listed as N/A, the quarter-over-quarter change is N/A, and the only historical value provided is the current 1.1% for the most recent period, so no trend direction can be assessed. The combination of a low growth level with no observable trend indicates limited current momentum relative to peers, which raises caution for near-term sales performance. This metric supports the overall NEUTRAL verdict, as the weak growth is consistent with a balanced outlook that does not warrant a bullish or bearish stance.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about BIO?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does BIO's Revenue Growth (YoY) compare to its sector?

BIO's Revenue Growth (YoY) of -0.1% compares to a Healthcare sector median of 10.0%, placing it in the 13th percentile.

Who are BIO's closest peers by Revenue Growth (YoY)?

The closest Healthcare peers by Revenue Growth (YoY) include: A (10.0%), DGX (10.2%), RMD (10.8%), CAH (11.0%), BSX (11.6%).

📚

Learn More About Revenue Growth (YoY)

How to Analyze Revenue Growth: More Than Just Rising Sales

Learn how to analyze revenue growth beyond the headline number. Master absolute vs percentage, YoY vs QoQ, and sustainable growth with real examples from NVDA, GOOGL, and MDB.

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.